Coptis Teeta

Coptis teeta  Wall.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Ranunculaceae.
Habitat Mishmi Hills in Arunachal Pradesh. Cultivated commercially in China.
Ayurvedic Mamira, Maamiraa, Tiktamuulaa. (Pita-muulikaa and Hem-tantu are provisional synonyms.)
Unani Maamisaa, Maamiraa.
Folk Titaa (Bengal and Assam).
Action Stomachic, antiperiodic, antibacterial, antifungal. Prescribed in debility, convalescence, intermittent fevers, dyspepsia, dysentery and intestinal catarrh. Used as a local application in thrush.
Dosage Root—1–3 g powder. (CCRAS.)
Taxonomic Cohort Genus Coptis (1 documented species); Family Ranunculaceae (32 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Coptis teeta (taxonomically cited with authority Wall.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Ranunculaceae (primary family classification: Ranunculaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Mishmi Hills in Arunachal Pradesh. Cultivated commercially in China.

Across classical and vernacular Indian systems of medicine, Coptis teeta is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Mamira, Maamiraa, Tiktamuulaa. (Pita-muulikaa and Hem-tantu are provisional synonyms.); in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Maamisaa, Maamiraa; in regional Indian folk and vernacular ethnobotany as Titaa (Bengal and Assam). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Coptis teeta are: Stomachic, antiperiodic, antibacterial, antifungal. Prescribed in debility, convalescence, intermittent fevers, dyspepsia, dysentery and intestinal catarrh. Used as a local application in thrush. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Coptis teeta establish the following evidence base: The rhizomes contains berberine (9%) as the major alkaloid; other alkaloids present are: coptin (0.08%), coptisin 0.02%) and jatrorrhizine (0.01%). Samples from China contained 9.26– 12.23% berberine, 2.39–3.25% coptisin and 3.20–4.46% jatrorrhizine. In China, the herb is used as an antidiabetic; the ethanolic (50%) extract exhibited hypoglycaemic and hypotensive activity. The drug due to berberine and its related alkaloids promoted reticuloendothelium to increased phagocytosis of leucocytes in dog blood in vitro and in vivo. Coptis chinensis (Huang Lian) inhibited erythrocyte haemolysis, decreased lipid peroxidation in brain and kidney, decreased generation of superoxide peroxidation and decreased hydroxyl radicals in rats. (Life Sci, 2000, 66(8), 725–735.)

In specialized pharmacognostic classifications, Coptis teeta is also represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

image1

Figure 1: Authenticated crude herb specimen — Coptis teeta rhizome.

image3

Botanical Reference 1: Coptis teeta — Botanical specimen

image4

Botanical Reference 2: Coptis teeta — Botanical specimen

image5

Botanical Reference 3: Coptis teeta — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Coptis teeta stands as a distinct representative of the genus Coptis. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Ranunculaceae encompasses 32 documented medicinal species (1.76% of the 1,814-species flora). Other representative medicinal members of Ranunculaceae include: Aconitum atrox (Vatsanaabha), Aconitum chasmanthum (Visha), Aconitum deinorrhizum (Vatsanaabha), Aconitum falconeri (Vatsanaabha), Actaea spicata (Baneberry Grapewort). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image2

Figure 2: Quantitative documentation profile across all 32 medicinal species of family Ranunculaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

For clinical and traditional dispensing, the standardized posology and crude herb dosage for Coptis teeta are prescribed as follows: Root—1–3 g powder. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Coptis teeta integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top